Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41


Intercellular Communication between Hepatic Cells in Liver Diseases.

Sato K, Kennedy L, Liangpunsakul S, Kusumanchi P, Yang Z, Meng F, Glaser S, Francis H, Alpini G.

Int J Mol Sci. 2019 May 2;20(9). pii: E2180. doi: 10.3390/ijms20092180. Review.


Dual Role of Bile Acids on the Biliary Epithelium: Friend or Foe?

Baiocchi L, Zhou T, Liangpunsakul S, Lenci I, Santopaolo F, Meng F, Kennedy L, Glaser S, Francis H, Alpini G.

Int J Mol Sci. 2019 Apr 16;20(8). pii: E1869. doi: 10.3390/ijms20081869. Review.


Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets.

Sato K, Glaser S, Kennedy L, Liangpunsakul S, Meng F, Francis H, Alpini G.

Expert Opin Ther Targets. 2019 Jun;23(6):461-472. doi: 10.1080/14728222.2019.1608950. Epub 2019 Apr 22.


Hepatocyte-specific and extra-hepatocyte actions of perilipin-2 during fatty liver disease: benefits of being extra.

Kennedy L, Francis H, Alpini G.

J Physiol. 2019 Mar;597(6):1431-1432. doi: 10.1113/JP277539. Epub 2019 Jan 29. No abstract available.


Comprehensive Review of Molecular Mechanisms during Cholestatic Liver Injury and Cholangiocarcinoma.

Virani S, Akers A, Stephenson K, Smith S, Kennedy L, Alpini G, Francis H.

J Liver. 2018;7(3). pii: 231. doi: 10.4172/2167-0889.1000231. Epub 2018 Sep 20.


Ursodeoxycholate inhibits mast cell activation and reverses biliary injury and fibrosis in Mdr2-/- mice and human primary sclerosing cholangitis.

Meng F, Kennedy L, Hargrove L, Demieville J, Jones H, Madeka T, Karstens A, Chappell K, Alpini G, Sybenga A, Invernizzi P, Bernuzzi F, DeMorrow S, Francis H.

Lab Invest. 2018 Nov;98(11):1465-1477. doi: 10.1038/s41374-018-0101-0. Epub 2018 Aug 24.


Therapeutic Role of Sphingosine-1-Phosphate Receptor 2 in the Progression of Esophageal Adenocarcinoma.

Kennedy L, Alpini G.

Am J Pathol. 2018 Sep;188(9):1949-1952. doi: 10.1016/j.ajpath.2018.07.001. Epub 2018 Jul 17.


Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2-/- mice and human cholangiocarcinoma tumorigenesis.

Kennedy L, Hargrove L, Demieville J, Karstens W, Jones H, DeMorrow S, Meng F, Invernizzi P, Bernuzzi F, Alpini G, Smith S, Akers A, Meadows V, Francis H.

Hepatology. 2018 Mar 30. doi: 10.1002/hep.29898. [Epub ahead of print]


Cellular crosstalk during cholestatic liver injury.

Thomson J, Hargrove L, Kennedy L, Demieville J, Francis H.

Liver Res. 2017 Jun;1(1):26-33. doi: 10.1016/j.livres.2017.05.002. Epub 2017 May 10.


Dual ablation of β- and γ-catenin: Critical regulators of junctions and their functions.

Francis H, Kennedy L, Alpini G.

Hepatology. 2018 Jun;67(6):2079-2081. doi: 10.1002/hep.29761. Epub 2018 Apr 19. No abstract available.


Knockout of l-Histidine Decarboxylase Prevents Cholangiocyte Damage and Hepatic Fibrosis in Mice Subjected to High-Fat Diet Feeding via Disrupted Histamine/Leptin Signaling.

Kennedy L, Hargrove L, Demieville J, Bailey JM, Dar W, Polireddy K, Chen Q, Nevah Rubin MI, Sybenga A, DeMorrow S, Meng F, Stockton L, Alpini G, Francis H.

Am J Pathol. 2018 Mar;188(3):600-615. doi: 10.1016/j.ajpath.2017.11.016. Epub 2017 Dec 15.


Student pharmacist experiences as inpatient psychiatry medication education group leaders during an early immersion program.

McLaughlin JE, Kennedy L, Garris S, Harris SC, Hillman A, Pinelli NR, Rhoney DH.

Curr Pharm Teach Learn. 2017 Sep;9(5):856-861. doi: 10.1016/j.cptl.2017.06.005. Epub 2017 Sep 1.


Regulation of Cellular Senescence by miR-34a in Alcoholic Liver Injury.

Wan Y, McDaniel K, Wu N, Ramos-Lorenzo S, Glaser T, Venter J, Francis H, Kennedy L, Sato K, Zhou T, Kyritsi K, Huang Q, Annable T, Wu C, Glaser S, Alpini G, Meng F.

Am J Pathol. 2017 Dec;187(12):2788-2798. doi: 10.1016/j.ajpath.2017.08.027. Epub 2017 Nov 8.


Updates on Dietary Models of Nonalcoholic Fatty Liver Disease: Current Studies and Insights.

Stephenson K, Kennedy L, Hargrove L, Demieville J, Thomson J, Alpini G, Francis H.

Gene Expr. 2018 Mar 21;18(1):5-17. doi: 10.3727/105221617X15093707969658. Epub 2017 Nov 2.


Recent Advances in Understanding Cholangiocarcinoma.

Kennedy L, Hargrove L, Demieville J, Francis N, Seils R, Villamaria S, Francis H.

F1000Res. 2017 Oct 9;6:1818. doi: 10.12688/f1000research.12118.1. eCollection 2017. Review.


Impact of prevailing thiamin levels on thiamin pyrophosphate uptake in pancreatic acinar cells: do the shuttle!

Kennedy L, Francis H, Alpini G.

Am J Physiol Gastrointest Liver Physiol. 2017 Nov 1;313(5):G373-G375. doi: 10.1152/ajpgi.00256.2017. Epub 2017 Aug 24. No abstract available.


Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.

Wu N, Meng F, Zhou T, Han Y, Kennedy L, Venter J, Francis H, DeMorrow S, Onori P, Invernizzi P, Bernuzzi F, Mancinelli R, Gaudio E, Franchitto A, Glaser S, Alpini G.

FASEB J. 2017 Oct;31(10):4305-4324. doi: 10.1096/fj.201700097R. Epub 2017 Jun 20.


Knockdown of Hepatic Gonadotropin-Releasing Hormone by Vivo-Morpholino Decreases Liver Fibrosis in Multidrug Resistance Gene 2 Knockout Mice by Down-Regulation of miR-200b.

Kyritsi K, Meng F, Zhou T, Wu N, Venter J, Francis H, Kennedy L, Onori P, Franchitto A, Bernuzzi F, Invernizzi P, McDaniel K, Mancinelli R, Alvaro D, Gaudio E, Alpini G, Glaser S.

Am J Pathol. 2017 Jul;187(7):1551-1565. doi: 10.1016/j.ajpath.2017.03.013. Epub 2017 May 12.


The emerging role of mast cells in liver disease.

Jarido V, Kennedy L, Hargrove L, Demieville J, Thomson J, Stephenson K, Francis H.

Am J Physiol Gastrointest Liver Physiol. 2017 Aug 1;313(2):G89-G101. doi: 10.1152/ajpgi.00333.2016. Epub 2017 May 4. Review.


Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells.

Wan Y, Meng F, Wu N, Zhou T, Venter J, Francis H, Kennedy L, Glaser T, Bernuzzi F, Invernizzi P, Glaser S, Huang Q, Alpini G.

Hepatology. 2017 Aug;66(2):528-541. doi: 10.1002/hep.29138. Epub 2017 Jun 19.

Supplemental Content

Loading ...
Support Center